Recs

0
Player Avatar rstruyk (34.28) Submitted: 12/18/2012 3:59:14 PM : Outperform Start Price: $97.29 ALXN Score: -1.98

everyone loves this stock. It wasn't just added to the S&P 500 for no reason. Earnings, Sales, ROE are all exceptional. Created a niche market for rare diseases and management will continue to outperform expectations.

Featured Broker Partners


Advertisement